Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Theres no separate deductible to meet, no coinsurance percentage, and no coverage gap (donut hole) complications specific to this benefit
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
It can raise the risk of spreading cancer if a cancerous tumor that hadn't been found earlier gets broken up with morcellation during a myomectomy procedure
16 : DIABETES DRUGS MARKET BY TECHNOLOGY SEGMENT ANALYSIS 76 16.1
US$ 24.34
US$ 29.50
US$ 20.11
US$ 21.96
